Onconetix, Inc. — Director's Dealing 2022

May 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-05-04

Reporting Person: SAPIRSTEIN JAMES (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-04	Stock Option	$6.45	A	50575	Acquired	2032-05-04	Common Stock, par value $0.00001 per share (50575)	Direct

Footnotes

F1: Stock options (the "Options") were granted to Mr. Sapirstein on May 4, 2022. The Options vest and become exercisable as follows: (A) with respect to 45,920 of the Options: (i) 1,912 Options vested immediately upon grant; (ii) 956 Options vest at the end of each calendar month from the date of issuance through January 31, 2026 and (iii) the remaining 988 Options vest on February 28, 2026 and (B) with respect to 4,655 of the Options: (i) (1) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023 and (iii) the remaining 389 Options vest on March 31, 2023.